Literature DB >> 29884535

Synthesis and anti-proliferative activity of allogibberic acid derivatives containing 1,2,3-triazole pharmacophore.

Ming-Jiang Wu1, Dong-Mei Wu2, Jing-Bo Chen1, Jing-Feng Zhao1, Liang Gong3, Ya-Xiao Gong3, Yan Li4, Xiao-Dong Yang5, Hongbin Zhang6.   

Abstract

Sixty novel allogibberic acid derivatives containing 1,2,3-triazole pharmacophore were designed and synthesized. The key chemical processes include aromatization of the A ring in gibberellins, formation of allogibberic azides and its copper mediated Huisgen 1,3-dipolar cycloaddition with alkynes. A number of hybrids containing α,β-unsaturated ketone moiety exhibited excellent in vitro cytotoxic activities. Some of the hybrids were more selective to MCF-7 and SW480 cell lines with IC50 values at least 8-fold more cytotoxic than cisplatin (DDP). The most potent compounds C43 and C45 are more cytotoxic than cisplatin (DDP) against all tested five tumor cell lines, with IC50 values of 0.25-1.72 µM. Mechanism of action studies indicated that allogibberic-triazole derivative C45 could induce the S phase cell cycle arrest and apoptosis in SMMC-7721 cell lines.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1,2,3-Triazole; Allogibberic acid; Apoptosis; Cell cycle; Cytotoxic activity

Mesh:

Substances:

Year:  2018        PMID: 29884535     DOI: 10.1016/j.bmcl.2018.05.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Synthesis and Characterization of Bimetallic Nanoclusters Stabilized by Chiral and Achiral Polyvinylpyrrolidinones. Catalytic C(sp3)-H Oxidation.

Authors:  Huafang Fan; Zongbo Tong; Zhaoyang Ren; Kanchan Mishra; Shunya Morita; Edruce Edouarzin; Lingaraju Gorla; Boris Averkiev; Victor W Day; Duy H Hua
Journal:  J Org Chem       Date:  2022-05-05       Impact factor: 4.198

Review 2.  1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.

Authors:  Khurshed Bozorov; Jiangyu Zhao; Haji A Aisa
Journal:  Bioorg Med Chem       Date:  2019-07-04       Impact factor: 3.641

3.  New Application of 1,2,4-Triazole Derivatives as Antitubercular Agents. Structure, In Vitro Screening and Docking Studies.

Authors:  Zbigniew Karczmarzyk; Marta Swatko-Ossor; Waldemar Wysocki; Monika Drozd; Grazyna Ginalska; Anna Pachuta-Stec; Monika Pitucha
Journal:  Molecules       Date:  2020-12-19       Impact factor: 4.411

Review 4.  CuAAC-ensembled 1,2,3-triazole-linked isosteres as pharmacophores in drug discovery: review.

Authors:  Alisha Rani; Gurjaspreet Singh; Akshpreet Singh; Ubair Maqbool; Gurpreet Kaur; Jandeep Singh
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 4.036

Review 5.  Fluorinated triazoles as privileged potential candidates in drug development-focusing on their biological and pharmaceutical properties.

Authors:  Ihsan Ullah; Muhammad Ilyas; Muhammad Omer; Muhammad Alamzeb; Muhammad Sohail
Journal:  Front Chem       Date:  2022-08-09       Impact factor: 5.545

6.  Synthesis and In Vitro Cytotoxicity and Antibacterial Activity of Novel 1,2,3-Triazol-5-yl-phosphonates.

Authors:  Anna Tripolszky; Emese Tóth; Pál Tamás Szabó; László Hackler; Beáta Kari; László G Puskás; Erika Bálint
Journal:  Molecules       Date:  2020-06-06       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.